Business Context and Reporting Period
This Form 8-K is a current report filed by Intelligent Bio Solutions Inc. (INBS), a Delaware corporation listed on The Nasdaq Stock Market LLC. The report covers events occurring on June 9, 2023, with the filing date of June 15, 2023. The company identifies itself as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the departure of a director:
- Resignation: Dr. George Margelis resigned as a member of the Board of Directors and the Audit Committee effective June 9, 2023.
- Reason: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
- Appointment: Current independent director Jonathan Hurd was appointed to the Audit Committee to fill the vacancy left by Dr. Margelis.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on financial performance, or specific risk factors beyond the standard disclosure of the director's departure. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the current composition of the Board of Directors and Audit Committee following Dr. Margelis's resignation.
- Confirm that Jonathan Hurd's appointment to the Audit Committee satisfies Nasdaq listing requirements for independent directors.
- Review subsequent filings (e.g., 10-Q or 10-K) for financial metrics, as this 8-K contains no financial data.